<code id='7726FF159E'></code><style id='7726FF159E'></style>
    • <acronym id='7726FF159E'></acronym>
      <center id='7726FF159E'><center id='7726FF159E'><tfoot id='7726FF159E'></tfoot></center><abbr id='7726FF159E'><dir id='7726FF159E'><tfoot id='7726FF159E'></tfoot><noframes id='7726FF159E'>

    • <optgroup id='7726FF159E'><strike id='7726FF159E'><sup id='7726FF159E'></sup></strike><code id='7726FF159E'></code></optgroup>
        1. <b id='7726FF159E'><label id='7726FF159E'><select id='7726FF159E'><dt id='7726FF159E'><span id='7726FF159E'></span></dt></select></label></b><u id='7726FF159E'></u>
          <i id='7726FF159E'><strike id='7726FF159E'><tt id='7726FF159E'><pre id='7726FF159E'></pre></tt></strike></i>

          explore

          explore

          author:knowledge    Page View:2
          Sammy Kimball for STAT

          Is Wegovy really a brain drug? Which Alzheimer’s disease treatment works best? And what’s the point of Threads?

          We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Megan Molteni joins us to explain the evolving science suggesting products like Wegovy are less weight loss drugs than treatments for human desire. We also explain why this summer is shaping up to be a pivotal moment for the treatment of Alzheimer’s and discuss our befuddlement with the latest social media platform.

          advertisement

          For more on what we cover, here’s the story on GLP-1 drugs and the brain; here’s the latest on Leqembi; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

          Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

          And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

          leisure time

          New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
          New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

          CMSAdministratorChiquitaBrooks-LaSureChipSomodevilla/GettyImagesWASHINGTON— EliLilly’slatestanti-amy

          read more
          Readout Newsletter: Biotech news, Wall Street disappointment, Lilly's drug delays
          Readout Newsletter: Biotech news, Wall Street disappointment, Lilly's drug delays

          DarronCummings/APWanttostayontopofthescienceandpoliticsdrivingbiotechtoday? Signup togetourbiotechne

          read more
          ChatGPT in medicine: STAT answers readers' burning questions
          ChatGPT in medicine: STAT answers readers' burning questions

          MikeReddyforSTATArtificialintelligenceisoftendescribedasablackbox:anunknowable,mysteriousforcethatop

          read more

          Nobel honors Karikó and Weissman's enduring partnership

          DrewWeissman(left)andKatalinKarikó,whoselongtimepartnershipwasrecognizedwithaNobelPrizeonMonday.Pegg